A carregar...
Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant
Ozurdex (Allergan, Irvine, California, USA) is a biodegradable sustained release intravitreal implant containing 0.7 mg dexamethasone in a solid polymer drug delivery system. In the UK, it is approved for use in patients with macular oedema secondary to retinal vein occlusion, diabetic maculopathy a...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301585/ https://ncbi.nlm.nih.gov/pubmed/30567246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-227055 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|